A detailed history of North Forty Two & Co. transactions in Amgen Inc stock. As of the latest transaction made, North Forty Two & Co. holds 2,039 shares of AMGN stock, worth $696,746. This represents 0.56% of its overall portfolio holdings.

Number of Shares
2,039
Previous 2,429 16.06%
Holding current value
$696,746
Previous $678 Million 15.16%
% of portfolio
0.56%
Previous 0.72%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$271.18 - $309.22 $105,760 - $120,595
-390 Reduced 16.06%
2,039 $575 Million
Q2 2025

Aug 11, 2025

BUY
$262.28 - $309.85 $2,360 - $2,788
9 Added 0.37%
2,429 $678 Million
Q4 2024

Feb 10, 2025

BUY
$258.78 - $328.31 $626,247 - $794,510
2,420 New
2,420 $631 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track North Forty Two & Co. Portfolio

Follow North Forty Two & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Forty Two & Co., based on Form 13F filings with the SEC.

News

Stay updated on North Forty Two & Co. with notifications on news.